Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
Director departure
Appointed director
LIBERATOR MEDICAL HOLDINGS, INC. (LBMH) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/01/2016 SC 13D/A LIBRATORE MARK A reports a 0% stake in LIBERATOR MEDICAL HOLDINGS, INC.
01/26/2016 SC 13D/A MILLENNIUM PARTNERS, L.P. reports a 0% stake in Liberator Medical Holdings, Inc.
01/22/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
01/22/2016 4 Leger John (COO) has filed a Form 4 on LIBERATOR MEDICAL HOLDINGS, INC.
01/22/2016 4 SPRINKLE PHILIP (Director) has filed a Form 4 on LIBERATOR MEDICAL HOLDINGS, INC.
Txns: Disposed/sold 22,026 shares @ $3.35, valued at $73.8k
01/22/2016 4 LIBRATORE MARK A (President and CEO) has filed a Form 4 on LIBERATOR MEDICAL HOLDINGS, INC.
01/22/2016 4 WICK TYLER SHAW (Director) has filed a Form 4 on LIBERATOR MEDICAL HOLDINGS, INC.
01/22/2016 4 CORBETT JEANNETTE MARIA (Director) has filed a Form 4 on LIBERATOR MEDICAL HOLDINGS, INC.
01/22/2016 4 DAVIS ROBERT JOSEPH (CFO) has filed a Form 4 on LIBERATOR MEDICAL HOLDINGS, INC.
01/21/2016 4 BARD C R INC /NJ/ (10% Owner) has filed a Form 4 on LIBERATOR MEDICAL HOLDINGS, INC.
Txns: Bought 1,000 shares @ $0.01, valued at $10
01/21/2016 SC 13D/A BARD C R INC reports a 100% stake in Liberator Medical Holdings, Inc.
01/21/2016 8-K Quarterly results
01/07/2016 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
01/07/2016 8-K Other Events, Financial Statements and Exhibits
Docs: "ISS and Glass Lewis Recommend that Liberator Medical Shareholders Vote “FOR” Merger Agreement with C. R. Bard, Inc. STUART, Fla., January 7, 2016 -- Liberator Medical Holdings, Inc. announced today that two leading proxy-advisory firms have recommended that Liberator's shareholders vote “FOR” the approval of the merger agreement with C. R. Bard, Inc. at the special meeting of the shareholders being held on January 20, 2016. In its January 5, 2016 report, Institutional Shareholder Services Inc. , a leading independent proxy voting and corporate governance advisory firm stated: “A vote FOR this proposal is warranted given the one-day and two-month premium of 25.9 percent and 28.8 percent, respectively, the robust sales process conducted by [Liberator], and the certainty of value offered by ..."
12/29/2015 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
12/22/2015 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Liberator Medical Announces Definitive Settlement of Qui Tam Litigation",
"Settlement Agreement, entered into among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General (OIG-HHS) of the Department of Health and Human Services (HHS), Liberator Medical Supply, Inc., and relators Kimberly Herman, Amy Lestage, and Kevin Roseff, through their authorized representatives"
12/15/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
12/14/2015 8-K Quarterly results
Docs: "FY 2015 FY 2014 Change Net Sales $ 81,602 $ 74,569 9.4% Operating income 11,947 12,709 -6.0% Net income 7,308 7,802 -6.3% Earnings per diluted share 0.14 0.15 -6.7% Dividends declared per share $ 0.13 $ 0.12 8.3% Net sales for fiscal year 2015 increased by $7,033,000, or 9.4%, to $81,602,000, compared with sales of $74,569,000 for fiscal year 2014. The increase in sales was primarily due to the Company's continued emphasis on its direct response advertising campaign to acquire new customers and the Company's emphasis on customer service to maximize the reorder rates for its recurring customer base. Income from operations for fiscal year 2015 decreased by $762,000, or 6.0%, to $11,947,000, compared with fiscal year 2014. The decrease in operating income was primarily attributed to increases..."
12/14/2015 10-K Annual Report for the period ended September 30, 2015
12/10/2015 SC 13D/A MILLENNIUM PARTNERS, L.P. reports a 6.2% stake in Liberator Medical Holdings, Inc.
12/04/2015 SC 13D LIBRATORE MARK A reports a 36.6% stake in LIBERATOR MEDICAL HOLDINGS, INC.
12/04/2015 4 WICK TYLER SHAW (Director) has filed a Form 4 on LIBERATOR MEDICAL HOLDINGS, INC.
12/04/2015 4 Leger John (COO) has filed a Form 4 on LIBERATOR MEDICAL HOLDINGS, INC.
12/04/2015 4 DAVIS ROBERT JOSEPH (CFO) has filed a Form 4 on LIBERATOR MEDICAL HOLDINGS, INC.
12/04/2015 4 LIBRATORE MARK A (President and CEO) has filed a Form 4 on LIBERATOR MEDICAL HOLDINGS, INC.
11/30/2015 SC 13D GAMCO INVESTORS, INC. ET AL reports a 3.7% stake in Liberator Medical Holdings, Inc.
11/25/2015 SC 13D/A MILLENNIUM PARTNERS, L.P. reports a 7.3% stake in Liberator Medical Holdings, Inc.
11/24/2015 SC 13D BARD C R INC reports a 37.9% stake in LIBERATOR MEDICAL HOLDINGS, INC.
11/24/2015 SC 13D MILLENNIUM PARTNERS, L.P. reports a 8.3% stake in Liberator Medical Holdings, Inc.
11/20/2015 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger, by and among Liberator Medical Holdings, Inc., C. R. Bard, Inc. and Freedom MergerSub, Inc",
"Voting and Support Agreement, by and among C. R. Bard, Inc., Mark A. Libratore and Robert Davis",
"Non-Competition Agreement, by and among Liberator Medical Holdings, Inc., C. R. Bard, Inc., Freedom MergerSub, Inc. and Mark A. Libratore",
"Consultancy and Non-Competition Agreement, by and among Liberator Medical Holdings, Inc., C. R. Bard, Inc., Freedom MergerSub, Inc. and Robert Davis",
"Non-Competition Agreement, by and among Liberator Medical Holdings, Inc., C. R. Bard, Inc., Freedom MergerSub, Inc. and John Léger",
"Liberator Medical Holdings to be Acquired by C. R. Bard for Approximately $181 Million STUART, FLORIDA——November 20, 2015—Liberator Medical Holdings, Inc. , a leading national direct-to-consumer provider of quality medical supplies through its subsidiary, Liberator Medical Supply, Inc., today announced that it has entered into a definitive agreement to be acquired by C. R. Bard, Inc. , for a cash purchase price of $3.35 per fully-diluted share, or approximately $181 million in the aggregate. The purchase price represents a 36% premium over Liberator's average closing price during the 90 trading days ended November 19, 2015. The transaction is expected to close in the first quarter of 2016, subject to approval by Liberator's shareholders, satisfaction of customary closing conditions and rec..."
11/20/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
10/21/2015 4 WICK TYLER SHAW (Director) has filed a Form 4 on LIBERATOR MEDICAL HOLDINGS, INC.
09/11/2015 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Remarks of President and Chief Executive at the Company's Annual Stockholders Meeting on September 11, 2015"
08/26/2015 8-K Financial Statements and Exhibits
Docs: "Liberator Medical Declares Cash Dividend of $0.0325 per Share This Is the 11th Consecutive Quarterly Cash Dividend and Is to Be Paid to Shareholders of Record at the Close of Business on September 25, 2015 STUART, FL -- -- 08/25/15 -- Liberator Medical Holdings, Inc. today announced that on August 25, 2015, its Board of Directors approved a cash dividend of $0.0325 per common share to its shareholders. The dividend will be paid on October 9, 2015, to all shareholders of record as of the close of business on September 25, 2015. This is the eleventh consecutive quarterly cash dividend to be paid by the Company, commencing with the dividend paid in May 2013. The Company's policy is to pay a sustainable quarterly dividend to its shareholders. The Company's Board of Directors evaluates on a qua..."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy